Healthcare focused edtech startup Virohan has raised Rs 65 crore ($7.5 million) as part of its ongoing Series B funding round, led by Japan based Mynavi Corporation. The round also witnessed participation from existing investors, including Blume Ventures, Bharat Inclusive Technologies Seed Fund, and Rebright Partners, reinforcing continued confidence in the company’s growth trajectory.
The fresh capital will be utilised to accelerate Virohan’s journey towards profitability, with a sharp focus on product innovation, operational efficiencies, and strategic talent expansion, the company said in a statement. Entrackr had earlier exclusively reported the development.
Founded in 2018, Virohan operates at the intersection of education and healthcare workforce development. The company collaborates with leading universities such as UPES, BBD University, CMR University, Assam Don Bosco University, and G.H. Raisoni University to offer undergraduate programmes in allied healthcare, nursing, and healthcare management. On the industry side, it partners with healthcare employers including Lenskart, Medanta, Healthians, and Dr. Lal PathLabs to facilitate student placements and improve employability outcomes.
Over the past seven years, Virohan claims to have partnered with more than 20 higher education institutions, trained over 13,000 healthcare students, and worked with 2,000+ healthcare employers, positioning itself as a key talent pipeline for India’s growing healthcare sector.
Virohan has raised over $25 million in funding to date. As per data from TheKredible, following the latest share allotment, Mynavi Corporation will hold a 3.83% stake, while Blume Ventures remains the largest shareholder with a 16.16% stake.
The company is yet to file its FY25 financials. In FY24, Virohan reported operating revenue of Rs 21 crore, nearly doubling from Rs 10.65 crore in FY23, while losses widened 18% year on year to Rs 22 crore, reflecting continued investments in scale and capability building.
Follow Startupbydoc for daily startup insights, funding news, IPO analysis, and business breakdowns.